Co-Authors
This is a "connection" page, showing publications co-authored by JESSICA P HWANG and MARIA SUAREZ-ALMAZOR.
Connection Strength
4.006
-
Models to Predict Hepatitis B Virus Infection Among Patients With Cancer Undergoing Systemic Anticancer Therapy: A Prospective Cohort Study. J Clin Oncol. 2018 Apr 01; 36(10):959-967.
Score: 0.627
-
Trends in hepatitis B virus screening at the onset of chemotherapy in a large US cancer center. BMC Cancer. 2013 Nov 09; 13:534.
Score: 0.466
-
Attitudes toward hepatitis B virus among Vietnamese, Chinese and Korean Americans in the Houston area, Texas. J Community Health. 2012 Oct; 37(5):1091-100.
Score: 0.432
-
Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study. BMJ Support Palliat Care. 2012 Dec; 2(4):344-50.
Score: 0.427
-
Low rates of hepatitis B virus screening at the onset of chemotherapy. J Oncol Pract. 2012 Jul; 8(4):e32-9.
Score: 0.423
-
Medical care of hepatitis B among Asian American populations: perspectives from three provider groups. J Gen Intern Med. 2010 Mar; 25(3):220-7.
Score: 0.357
-
Cervical Cancer Screening in Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2021 12; 73(12):1796-1803.
Score: 0.202
-
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study. Support Care Cancer. 2021 Jan; 29(1):97-105.
Score: 0.182
-
Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. JCO Clin Cancer Inform. 2019 03; 3:1-12.
Score: 0.168
-
Passive transfer of anti-HBc after intravenous immunoglobulin administration in patients with cancer: a retrospective chart review. Lancet Haematol. 2018 Oct; 5(10):e474-e478.
Score: 0.164
-
Low Rate of Cervical Cancer Screening among Women with Hematologic Malignancies after Stem Cell Transplant. Biol Blood Marrow Transplant. 2018 05; 24(5):1094-1098.
Score: 0.157
-
Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy. Cancer. 2017 Sep 01; 123(17):3367-3376.
Score: 0.149
-
HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract. 2015 Sep; 11(5):384-90.
Score: 0.132
-
Hepatitis C virus screening in patients with cancer receiving chemotherapy. J Oncol Pract. 2014 May; 10(3):e167-74.
Score: 0.119